EQL Pharma AB financial statements
EQL Pharma AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | SEK 432.66M | Annual report |
| Net income | SEK 12.54M | Annual report |
| Cash and equivalents | SEK 86.76M | Annual report |